Showing results (471-480 of 3,904) with videos related to

Sort By:
Pageof 391
American Journal of Cancer Research|June 7, 2021
Mitochondrial structural alterations in ovarian cancer patient-derived xenografts resistant to cisplatinFrancesca Ricci, Alessandro Corbelli, Roberta Affatato, et al.
American Journal of Cancer Research|June 7, 2021
Alpha-fetoprotein response at different time-points is associated with efficacy of nivolumab monotherapy for unresectable hepatocellular carcinomaWei Teng, Chen-Chun Lin, Ming-Mo Ho, et al.
American Journal of Cancer Research|June 7, 2021
Association of pretreatment body mass index with risk of head and neck cancer: a large single-center studyAnshu Khanna, Eric M Sturgis, Kristina R Dahlstrom, et al.
American Journal of Cancer Research|January 8, 2021
Primary malignant melanomas of the female lower genital tract: clinicopathological characteristics and managementDongying Wang, Tianmin Xu, He Zhu, et al.
American Journal of Cancer Research|January 8, 2021
Oncogene UBE2I enhances cellular invasion, migration and proliferation abilities via autophagy-related pathway resulting in poor prognosis in hepatocellular carcinomaXiang-Kun Wang, Xi-Wen Liao, Xin Zhou, et al.
American Journal of Cancer Research|January 8, 2021
Identification of DHX36 as a tumour suppressor through modulating the activities of the stress-associated proteins and cyclin-dependent kinases in breast cancerYinduo Zeng, Tao Qin, Valentina Flamini, et al.
American Journal of Cancer Research|January 8, 2021
Potential predictive value of serum targeted metabolites and concurrently mutated genes for EGFR-TKI therapeutic efficacy in lung adenocarcinoma patients with EGFR sensitizing mutationsXiaohong Han, Rongrong Luo, Lin Wang, et al.
American Journal of Cancer Research|January 8, 2021
The CDK6-c-Jun-Sp1-MMP-2 axis as a biomarker and therapeutic target for triple-negative breast cancerChi-Wen Luo, Ming-Feng Hou, Chia-Wei Huang, et al.
American Journal of Cancer Research|January 8, 2021
Effects of α1-adrenergic receptor antagonists on the development and progression of urothelial cancerYujiro Nagata, Takashi Kawahara, Takuro Goto, et al.
American Journal of Cancer Research|January 8, 2021
The novel potent TEAD inhibitor, K-975, inhibits YAP1/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesotheliomaAyumi Kaneda, Toshihiro Seike, Tomohiro Danjo, et al.
Pageof 391